General Meeting of Shareholders appoints Rolf-Dieter Schwalb to DSM Managing Board of Directors

10/19/2006, 3:15 PM (Source: GlobeNewswire)

Today, the General Meeting of Shareholders appointed Mr Rolf-Dieter
Schwalb as Member of the Managing Board of Directors and Chief
Financial Officer (CFO) of DSM.

Rolf-Dieter Schwalb (54), born and raised in Germany, is an all round
and experienced CFO at Board level with business experience, who
masters all the functional areas of the finance function. He has
extensive experience with external stakeholders as well as with
acquisitions and divestments in various parts of the world, including
Asia. Before joining DSM Rolf-Dieter Schwalb was CFO and Member of
the Executive Board of Beiersdorf AG in Germany. Prior to that, he
had various responsibilities within Procter & Gamble.

DSM is active worldwide in nutritional and pharma ingredients,
performance materials and industrial chemicals. The company creates
innovative products and services that help improve the quality of
life. DSM's products are used in a wide range of end markets and
applications such as human and animal nutrition and health,
cosmetics, pharmaceuticals, automotive and transport, coatings,
housing and electrics & electronics (E&E). DSM's strategy, named
Vision 2010 - Building on Strengths, focuses on accelerating
profitable and innovative growth of the company's specialties
portfolio. Market-driven growth, innovation and increased presence in
emerging economies are key drivers of this strategy. The group has
annual sales of over EUR 8 billion and employs some 22,000 people
worldwide. DSM ranks among the global leaders in many of its fields.
The company is headquartered in the Netherlands, with locations in
Europe, Asia, Africa and the Americas. More information about DSM can
be found at

A picture of Rolf-Dieter Schwalb and his Curriculum Vitae are
available at

For more information:
DSM Corporate Communications DSM Investor Relations
Elvira Luykx Dries Ausems
tel. +31 (0) 45 tel. +31 (0) 45 5782864
5782035 fax +31 (0) 45 5782595
fax +31 (0) 45 e-mail

View document
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.